Quick answers
- What is Admelog?
- Admelog is a brand name of Insulin lispro, a prescription medicine. The FDA NDC Directory lists 4 Admelog products in 2 strengths and forms.
- Who makes Admelog?
- Sanofi-Aventis US holds the FDA application for Admelog (BLA209196, approved December 11, 2017). 1 other company (repackagers or distributors) also list Admelog products.
- Is there a generic or store brand of Admelog?
- Yes. The FDA NDC Directory lists 38 other products with the same active ingredients, strength and form as a Admelog product. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Admelog?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 Admelog strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Admelog been recalled?
- FDA enforcement reports list 2 recalls of Admelog products; the newest started April 11, 2023. A recall usually concerns specific lots, not every product.
What Admelog is
Each Admelog product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Insulin lispro · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| insulin lispro 100 units/mL injection, solution (intravenous, subcutaneous) | Admelog | 19 products, 2 companies | DailyMed |
| insulin lispro 100 units/mL injection, solution (subcutaneous) | Admelog | 19 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Insulin lispro →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA209196 | Sanofi-Aventis US | December 11, 2017 | 4 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| insulin lispro 100 units/mL injection, solution | Brand: Admelog | $9.39–$12.56 per mL 3 packages, lowest to highest Generic of the same strength and form: $2.40–$10.19 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Admelog
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Admelog products.
- Sanofi-Aventis U.S. LLC3 products
- Remedyrepack Inc.1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
April 11, 2023 · Class II · Ongoing · D-0575-2023
Lack of Assurance of Sterility: Malformed crimped collar seal
Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807 A Sanofi Company. NDC 0024-5926-05 — Sanofi-Aventis U.S. LLC
-
July 5, 2018 · Class II · Ongoing · D-0925-2018
Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0 — Sanofi-Aventis U.S. LLC
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.